Publications
Statistics and drug utilization: are prescribing rates really that high? CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienneCMAJ. 2001;165(11):1507-1508.
Quantifying components of drug expenditure inflation: the British Columbia seniors' drug benefit plan. Health services researchHealth Serv.Res.. 2002;37(5):1243-1266.
The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare? Journal of health services research & policyJ.Health Serv.Res.Policy. 2003;8(4):237-244.
Predictive genetic tests and health system costs. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienneCMAJ. 2003;168(8):989-991.
Whither seniors' pharmacare: lessons from (and for) Canada. Health affairs (Project Hope)Health.Aff.(Millwood). 2003;22(3):49-59.
Canadians confront health care reform. Health affairs (Project Hope)Health.Aff.(Millwood). 2004;23(3):186-193.
Internet pharmacy: prices on the up-and-up. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienneCMAJ. 2004;170(6):945-946.
An outcomes-based approach to decisions about drug coverage policies in British Columbia. Psychiatric services (Washington, D.C.)Psychiatr.Serv.. 2004;55(11):1230-1232.
Outcomes-based drug coverage in British Columbia. Health affairs (Project Hope)Health.Aff.(Millwood). 2004;23(3):269-276.
Persistence with hypertension treatment among community-dwelling BC seniors. The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie cliniqueCan.J.Clin.Pharmacol.. 2004;11(2):e267-73.
Post-Romanow pharmacare: last-dollar first...first-dollar lost? HealthcarePapersHealthc.Pap.. 2004;4(3):10-20.
Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia. Health policy (Amsterdam, Netherlands)Health Policy. 2004;68(3):299-307.
Who's the fairest of them all? Which provincial pharmacare model would best protect Canadians against catastrophic drug costs? Healthcare quarterly (Toronto, Ont.)Healthc.Q.. 2004;7(4):suppl 13-9.
Booming prescription drug expenditure: a population-based analysis of age dynamics. Medical careMed.Care. 2005;43(10):996-1008.
"Breakthrough" drugs and growth in expenditure on prescription drugs in Canada. BMJ (Clinical research ed.)BMJ. 2005;331(7520):815-816.
British Columbia Rx Atlas, 1st Edition. Vancouver (BC): UBC Centre for Health Services and Policy Research; 2005.
Canadian prescription drug costs surpass 18 billion dollars. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienneCMAJ. 2005;172(10):1323-1324.
Canadian Rx Atlas, 1st edition. UBC Centre for Health Services and Policy Research; 2005.
Drug expenditure trends in the Canadian provinces: magnitude and causes from 1998 to 2004. Healthcare policy = Politiques de santeHealthc.Policy.. 2005;1(1):85-99.
First-line first? Trends in thiazide prescribing for hypertensive seniors. PLoS medicinePLoS Med.. 2005;2(4):e80.
Medicine by media: did a critical television documentary affect the prescribing of cyproterone--estradiol (Diane-35)? CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienneCMAJ. 2005;173(11):1313-1315.
Centralising drug review to improve coverage decisions: economic lessons from (and for) Canada. Applied health economics and health policyAppl.Health.Econ.Health.Policy.. 2006;5(2):67-73.
Centralized drug review processes in Australia, Canada, New Zealand, and the United kingdom. Health affairs (Project Hope)Health.Aff.(Millwood). 2006;25(2):337-347.
The Common Drug Review: a NICE start for Canada? Health policy (Amsterdam, Netherlands)Health Policy. 2006;77(3):339-351.
Income-Based Drug Coverage in British Columbia: Lessons for BC and the Rest of Canada. Healthcare policy = Politiques de santeHealthc.Policy.. 2006;2(2):115-127.
